nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—breast cancer—Betamethasone—psoriasis	0.187	0.5	CpDpCtD
Estradiol—breast cancer—Dexamethasone—psoriasis	0.187	0.5	CpDpCtD
Estradiol—Testosterone—Hydrocortisone—psoriasis	0.0351	0.543	CrCrCtD
Estradiol—Testosterone—Prednisolone—psoriasis	0.0295	0.457	CrCrCtD
Estradiol—UGT1A1—Mycophenolic acid—psoriasis	0.0214	0.0542	CbGbCtD
Estradiol—CYP1A1—Clobetasol propionate—psoriasis	0.0201	0.051	CbGbCtD
Estradiol—ABCC10—Cyclosporine—psoriasis	0.0193	0.0489	CbGbCtD
Estradiol—SHBG—Hydrocortisone—psoriasis	0.0154	0.0389	CbGbCtD
Estradiol—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0142	0.036	CbGbCtD
Estradiol—UGT1A1—Mycophenolate mofetil—psoriasis	0.012	0.0303	CbGbCtD
Estradiol—CYP1A1—Methoxsalen—psoriasis	0.0106	0.0268	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—psoriasis	0.0102	0.0259	CbGbCtD
Estradiol—ABCC10—Methotrexate—psoriasis	0.0102	0.0259	CbGbCtD
Estradiol—ALB—Acitretin—psoriasis	0.00968	0.0245	CbGbCtD
Estradiol—AOX1—Methotrexate—psoriasis	0.00966	0.0245	CbGbCtD
Estradiol—CYP2C8—Tazarotene—psoriasis	0.00947	0.024	CbGbCtD
Estradiol—CYP3A5—Beclomethasone—psoriasis	0.00915	0.0232	CbGbCtD
Estradiol—CYP1A2—Clobetasol propionate—psoriasis	0.00899	0.0228	CbGbCtD
Estradiol—SLCO1B1—Mycophenolate mofetil—psoriasis	0.00828	0.021	CbGbCtD
Estradiol—SLCO1A2—Prednisolone—psoriasis	0.00743	0.0188	CbGbCtD
Estradiol—SLCO1A2—Hydrocortisone—psoriasis	0.00704	0.0178	CbGbCtD
Estradiol—SLCO1A2—Prednisone—psoriasis	0.00702	0.0178	CbGbCtD
Estradiol—CYP1A1—Cholecalciferol—psoriasis	0.007	0.0177	CbGbCtD
Estradiol—CYP1B1—Dexamethasone—psoriasis	0.0069	0.0175	CbGbCtD
Estradiol—SLCO1A2—Cyclosporine—psoriasis	0.00665	0.0169	CbGbCtD
Estradiol—ABCG2—Mycophenolate mofetil—psoriasis	0.00658	0.0167	CbGbCtD
Estradiol—SLCO1B1—Cyclosporine—psoriasis	0.00627	0.0159	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—psoriasis	0.0057	0.0144	CbGbCtD
Estradiol—ABCG2—Hydrocortisone—psoriasis	0.00528	0.0134	CbGbCtD
Estradiol—SLC22A11—Methotrexate—psoriasis	0.00527	0.0134	CbGbCtD
Estradiol—ABCG2—Cyclosporine—psoriasis	0.00498	0.0126	CbGbCtD
Estradiol—CYP1A2—Methoxsalen—psoriasis	0.00472	0.012	CbGbCtD
Estradiol—ALB—Mycophenolate mofetil—psoriasis	0.00453	0.0115	CbGbCtD
Estradiol—SLCO1A2—Dexamethasone—psoriasis	0.00438	0.0111	CbGbCtD
Estradiol—CYP2C8—Cholecalciferol—psoriasis	0.00404	0.0102	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0039	0.00988	CbGbCtD
Estradiol—CYP3A7—Hydrocortisone—psoriasis	0.0039	0.00988	CbGbCtD
Estradiol—CYP3A7—Cyclosporine—psoriasis	0.00368	0.00933	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00368	0.00933	CbGbCtD
Estradiol—CYP3A5—Mycophenolate mofetil—psoriasis	0.00364	0.00923	CbGbCtD
Estradiol—ALB—Prednisone—psoriasis	0.00362	0.00919	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—psoriasis	0.00352	0.00892	CbGbCtD
Estradiol—CYP2C8—Mycophenolate mofetil—psoriasis	0.0035	0.00888	CbGbCtD
Estradiol—CYP2C19—Cholecalciferol—psoriasis	0.00339	0.00859	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—psoriasis	0.00332	0.00842	CbGbCtD
Estradiol—ABCG2—Dexamethasone—psoriasis	0.00328	0.00832	CbGbCtD
Estradiol—CYP3A4—Calcitriol—psoriasis	0.00318	0.00806	CbGbCtD
Estradiol—SLC22A8—Methotrexate—psoriasis	0.00307	0.00777	CbGbCtD
Estradiol—CYP1A1—Dexamethasone—psoriasis	0.00303	0.00768	CbGbCtD
Estradiol—CYP3A5—Hydrocortisone—psoriasis	0.00292	0.00741	CbGbCtD
Estradiol—CYP2C9—Cholecalciferol—psoriasis	0.00282	0.00714	CbGbCtD
Estradiol—CYP2C8—Hydrocortisone—psoriasis	0.00281	0.00713	CbGbCtD
Estradiol—CYP3A5—Cyclosporine—psoriasis	0.00276	0.007	CbGbCtD
Estradiol—CYP2C8—Cyclosporine—psoriasis	0.00266	0.00673	CbGbCtD
Estradiol—ABCG2—Methotrexate—psoriasis	0.00264	0.00669	CbGbCtD
Estradiol—CYP3A4—Methoxsalen—psoriasis	0.00247	0.00627	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00242	0.00614	CbGbCtD
Estradiol—CYP3A7—Dexamethasone—psoriasis	0.00242	0.00614	CbGbCtD
Estradiol—ABCB1—Mycophenolate mofetil—psoriasis	0.00237	0.00601	CbGbCtD
Estradiol—CYP2C19—Prednisone—psoriasis	0.00235	0.00596	CbGbCtD
Estradiol—CYP2C19—Cyclosporine—psoriasis	0.00223	0.00565	CbGbCtD
Estradiol—ABCB1—Betamethasone—psoriasis	0.00203	0.00516	CbGbCtD
Estradiol—ABCB1—Prednisolone—psoriasis	0.00201	0.00509	CbGbCtD
Estradiol—ABCB1—Hydrocortisone—psoriasis	0.0019	0.00482	CbGbCtD
Estradiol—ABCB1—Prednisone—psoriasis	0.0019	0.0048	CbGbCtD
Estradiol—CYP2C9—Cyclosporine—psoriasis	0.00185	0.00469	CbGbCtD
Estradiol—CYP3A5—Dexamethasone—psoriasis	0.00182	0.00461	CbGbCtD
Estradiol—ALB—Methotrexate—psoriasis	0.00182	0.00461	CbGbCtD
Estradiol—ABCB1—Cyclosporine—psoriasis	0.0018	0.00455	CbGbCtD
Estradiol—CYP2C8—Dexamethasone—psoriasis	0.00175	0.00443	CbGbCtD
Estradiol—CYP3A4—Cholecalciferol—psoriasis	0.00164	0.00415	CbGbCtD
Estradiol—CYP2C19—Dexamethasone—psoriasis	0.00147	0.00372	CbGbCtD
Estradiol—CYP3A4—Triamcinolone—psoriasis	0.00142	0.0036	CbGbCtD
Estradiol—CYP3A4—Mycophenolate mofetil—psoriasis	0.00142	0.0036	CbGbCtD
Estradiol—CYP2C9—Dexamethasone—psoriasis	0.00122	0.00309	CbGbCtD
Estradiol—CYP3A4—Betamethasone—psoriasis	0.00122	0.00309	CbGbCtD
Estradiol—CYP3A4—Prednisolone—psoriasis	0.0012	0.00305	CbGbCtD
Estradiol—ABCB1—Dexamethasone—psoriasis	0.00118	0.003	CbGbCtD
Estradiol—CYP3A4—Hydrocortisone—psoriasis	0.00114	0.00289	CbGbCtD
Estradiol—CYP3A4—Prednisone—psoriasis	0.00114	0.00288	CbGbCtD
Estradiol—CYP3A4—Cyclosporine—psoriasis	0.00108	0.00273	CbGbCtD
Estradiol—ABCB1—Methotrexate—psoriasis	0.000951	0.00241	CbGbCtD
Estradiol—CYP3A4—Dexamethasone—psoriasis	0.000709	0.0018	CbGbCtD
Estradiol—Hypertension—Betamethasone—psoriasis	2.09e-05	0.000164	CcSEcCtD
Estradiol—Paraesthesia—Hydrocortisone—psoriasis	2.07e-05	0.000163	CcSEcCtD
Estradiol—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	2.07e-05	0.000163	CcSEcCtD
Estradiol—Urticaria—Cyclosporine—psoriasis	2.06e-05	0.000162	CcSEcCtD
Estradiol—Myalgia—Dexamethasone—psoriasis	2.06e-05	0.000161	CcSEcCtD
Estradiol—Myalgia—Betamethasone—psoriasis	2.06e-05	0.000161	CcSEcCtD
Estradiol—Abdominal pain—Cyclosporine—psoriasis	2.05e-05	0.000161	CcSEcCtD
Estradiol—Body temperature increased—Cyclosporine—psoriasis	2.05e-05	0.000161	CcSEcCtD
Estradiol—Anxiety—Betamethasone—psoriasis	2.05e-05	0.000161	CcSEcCtD
Estradiol—Anxiety—Dexamethasone—psoriasis	2.05e-05	0.000161	CcSEcCtD
Estradiol—Vomiting—Mycophenolic acid—psoriasis	2.04e-05	0.00016	CcSEcCtD
Estradiol—Discomfort—Betamethasone—psoriasis	2.03e-05	0.00016	CcSEcCtD
Estradiol—Discomfort—Dexamethasone—psoriasis	2.03e-05	0.00016	CcSEcCtD
Estradiol—Dyspepsia—Hydrocortisone—psoriasis	2.03e-05	0.000159	CcSEcCtD
Estradiol—Haemoglobin—Methotrexate—psoriasis	2.03e-05	0.000159	CcSEcCtD
Estradiol—Rash—Mycophenolic acid—psoriasis	2.02e-05	0.000159	CcSEcCtD
Estradiol—Dermatitis—Mycophenolic acid—psoriasis	2.02e-05	0.000159	CcSEcCtD
Estradiol—Pain—Prednisolone—psoriasis	2.02e-05	0.000159	CcSEcCtD
Estradiol—Haemorrhage—Methotrexate—psoriasis	2.02e-05	0.000159	CcSEcCtD
Estradiol—Hepatitis—Methotrexate—psoriasis	2.02e-05	0.000159	CcSEcCtD
Estradiol—Urticaria—Mycophenolate mofetil—psoriasis	2.01e-05	0.000158	CcSEcCtD
Estradiol—Headache—Mycophenolic acid—psoriasis	2.01e-05	0.000158	CcSEcCtD
Estradiol—Decreased appetite—Hydrocortisone—psoriasis	2.01e-05	0.000157	CcSEcCtD
Estradiol—Pharyngitis—Methotrexate—psoriasis	2e-05	0.000157	CcSEcCtD
Estradiol—Body temperature increased—Mycophenolate mofetil—psoriasis	2e-05	0.000157	CcSEcCtD
Estradiol—Abdominal pain—Mycophenolate mofetil—psoriasis	2e-05	0.000157	CcSEcCtD
Estradiol—Urinary tract disorder—Methotrexate—psoriasis	1.99e-05	0.000157	CcSEcCtD
Estradiol—Gastrointestinal disorder—Hydrocortisone—psoriasis	1.99e-05	0.000156	CcSEcCtD
Estradiol—Fatigue—Hydrocortisone—psoriasis	1.99e-05	0.000156	CcSEcCtD
Estradiol—Urethral disorder—Methotrexate—psoriasis	1.98e-05	0.000155	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Triamcinolone—psoriasis	1.98e-05	0.000155	CcSEcCtD
Estradiol—Pain—Hydrocortisone—psoriasis	1.97e-05	0.000155	CcSEcCtD
Estradiol—Anaphylactic shock—Dexamethasone—psoriasis	1.97e-05	0.000155	CcSEcCtD
Estradiol—Oedema—Dexamethasone—psoriasis	1.97e-05	0.000155	CcSEcCtD
Estradiol—Oedema—Betamethasone—psoriasis	1.97e-05	0.000155	CcSEcCtD
Estradiol—Anaphylactic shock—Betamethasone—psoriasis	1.97e-05	0.000155	CcSEcCtD
Estradiol—Insomnia—Triamcinolone—psoriasis	1.97e-05	0.000154	CcSEcCtD
Estradiol—Infection—Betamethasone—psoriasis	1.96e-05	0.000154	CcSEcCtD
Estradiol—Infection—Dexamethasone—psoriasis	1.96e-05	0.000154	CcSEcCtD
Estradiol—Ill-defined disorder—Prednisone—psoriasis	1.95e-05	0.000153	CcSEcCtD
Estradiol—Paraesthesia—Triamcinolone—psoriasis	1.95e-05	0.000153	CcSEcCtD
Estradiol—Feeling abnormal—Prednisolone—psoriasis	1.95e-05	0.000153	CcSEcCtD
Estradiol—Visual impairment—Methotrexate—psoriasis	1.95e-05	0.000153	CcSEcCtD
Estradiol—Shock—Dexamethasone—psoriasis	1.94e-05	0.000152	CcSEcCtD
Estradiol—Shock—Betamethasone—psoriasis	1.94e-05	0.000152	CcSEcCtD
Estradiol—Dyspnoea—Triamcinolone—psoriasis	1.94e-05	0.000152	CcSEcCtD
Estradiol—Nervous system disorder—Betamethasone—psoriasis	1.93e-05	0.000152	CcSEcCtD
Estradiol—Nervous system disorder—Dexamethasone—psoriasis	1.93e-05	0.000152	CcSEcCtD
Estradiol—Agitation—Prednisone—psoriasis	1.93e-05	0.000152	CcSEcCtD
Estradiol—Tachycardia—Betamethasone—psoriasis	1.92e-05	0.000151	CcSEcCtD
Estradiol—Tachycardia—Dexamethasone—psoriasis	1.92e-05	0.000151	CcSEcCtD
Estradiol—Angioedema—Prednisone—psoriasis	1.92e-05	0.000151	CcSEcCtD
Estradiol—Hypersensitivity—Cyclosporine—psoriasis	1.91e-05	0.00015	CcSEcCtD
Estradiol—Dyspepsia—Triamcinolone—psoriasis	1.91e-05	0.00015	CcSEcCtD
Estradiol—Erythema multiforme—Methotrexate—psoriasis	1.91e-05	0.00015	CcSEcCtD
Estradiol—Nausea—Mycophenolic acid—psoriasis	1.91e-05	0.00015	CcSEcCtD
Estradiol—Hyperhidrosis—Betamethasone—psoriasis	1.91e-05	0.00015	CcSEcCtD
Estradiol—Hyperhidrosis—Dexamethasone—psoriasis	1.91e-05	0.00015	CcSEcCtD
Estradiol—Feeling abnormal—Hydrocortisone—psoriasis	1.9e-05	0.000149	CcSEcCtD
Estradiol—Malaise—Prednisone—psoriasis	1.9e-05	0.000149	CcSEcCtD
Estradiol—Vertigo—Prednisone—psoriasis	1.89e-05	0.000148	CcSEcCtD
Estradiol—Eye disorder—Methotrexate—psoriasis	1.89e-05	0.000148	CcSEcCtD
Estradiol—Gastrointestinal pain—Hydrocortisone—psoriasis	1.89e-05	0.000148	CcSEcCtD
Estradiol—Syncope—Prednisone—psoriasis	1.89e-05	0.000148	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—psoriasis	1.88e-05	0.000148	CcSEcCtD
Estradiol—Urticaria—Prednisolone—psoriasis	1.88e-05	0.000147	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—psoriasis	1.87e-05	0.000147	CcSEcCtD
Estradiol—Fatigue—Triamcinolone—psoriasis	1.87e-05	0.000147	CcSEcCtD
Estradiol—Hypersensitivity—Mycophenolate mofetil—psoriasis	1.87e-05	0.000147	CcSEcCtD
Estradiol—Asthenia—Cyclosporine—psoriasis	1.86e-05	0.000146	CcSEcCtD
Estradiol—Pain—Triamcinolone—psoriasis	1.86e-05	0.000146	CcSEcCtD
Estradiol—Loss of consciousness—Prednisone—psoriasis	1.85e-05	0.000145	CcSEcCtD
Estradiol—Pruritus—Cyclosporine—psoriasis	1.84e-05	0.000144	CcSEcCtD
Estradiol—Urticaria—Hydrocortisone—psoriasis	1.83e-05	0.000144	CcSEcCtD
Estradiol—Angiopathy—Methotrexate—psoriasis	1.83e-05	0.000144	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—psoriasis	1.82e-05	0.000143	CcSEcCtD
Estradiol—Abdominal pain—Hydrocortisone—psoriasis	1.82e-05	0.000143	CcSEcCtD
Estradiol—Body temperature increased—Hydrocortisone—psoriasis	1.82e-05	0.000143	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—psoriasis	1.82e-05	0.000143	CcSEcCtD
Estradiol—Asthenia—Mycophenolate mofetil—psoriasis	1.82e-05	0.000143	CcSEcCtD
Estradiol—Hypertension—Prednisone—psoriasis	1.82e-05	0.000143	CcSEcCtD
Estradiol—Chills—Methotrexate—psoriasis	1.81e-05	0.000142	CcSEcCtD
Estradiol—ESR2—Generic Transcription Pathway—PPARG—psoriasis	1.8e-05	0.000467	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CYP2S1—psoriasis	1.8e-05	0.000467	CbGpPWpGaD
Estradiol—Musculoskeletal discomfort—Betamethasone—psoriasis	1.8e-05	0.000141	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Dexamethasone—psoriasis	1.8e-05	0.000141	CcSEcCtD
Estradiol—Pruritus—Mycophenolate mofetil—psoriasis	1.79e-05	0.000141	CcSEcCtD
Estradiol—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	1.79e-05	0.000464	CbGpPWpGaD
Estradiol—Myalgia—Prednisone—psoriasis	1.79e-05	0.000141	CcSEcCtD
Estradiol—Arthralgia—Prednisone—psoriasis	1.79e-05	0.000141	CcSEcCtD
Estradiol—Feeling abnormal—Triamcinolone—psoriasis	1.79e-05	0.000141	CcSEcCtD
Estradiol—Anxiety—Prednisone—psoriasis	1.79e-05	0.00014	CcSEcCtD
Estradiol—Alopecia—Methotrexate—psoriasis	1.78e-05	0.00014	CcSEcCtD
Estradiol—Insomnia—Betamethasone—psoriasis	1.78e-05	0.00014	CcSEcCtD
Estradiol—Insomnia—Dexamethasone—psoriasis	1.78e-05	0.00014	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	1.78e-05	0.00014	CcSEcCtD
Estradiol—SLC22A1—Metabolism—NDUFA5—psoriasis	1.78e-05	0.000461	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.78e-05	0.00046	CbGpPWpGaD
Estradiol—Diarrhoea—Cyclosporine—psoriasis	1.78e-05	0.000139	CcSEcCtD
Estradiol—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	1.77e-05	0.000459	CbGpPWpGaD
Estradiol—Paraesthesia—Betamethasone—psoriasis	1.77e-05	0.000139	CcSEcCtD
Estradiol—Paraesthesia—Dexamethasone—psoriasis	1.77e-05	0.000139	CcSEcCtD
Estradiol—NR1I2—Gene Expression—VDR—psoriasis	1.77e-05	0.000458	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CYP2S1—psoriasis	1.77e-05	0.000458	CbGpPWpGaD
Estradiol—Discomfort—Prednisone—psoriasis	1.77e-05	0.000139	CcSEcCtD
Estradiol—Mental disorder—Methotrexate—psoriasis	1.77e-05	0.000139	CcSEcCtD
Estradiol—AOX1—Metabolism—CARM1—psoriasis	1.77e-05	0.000458	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—NFKB1—psoriasis	1.77e-05	0.000457	CbGpPWpGaD
Estradiol—Malnutrition—Methotrexate—psoriasis	1.76e-05	0.000138	CcSEcCtD
Estradiol—Erythema—Methotrexate—psoriasis	1.76e-05	0.000138	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—NFKBIA—psoriasis	1.76e-05	0.000455	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—IL6—psoriasis	1.75e-05	0.000454	CbGpPWpGaD
Estradiol—Hypersensitivity—Prednisolone—psoriasis	1.74e-05	0.000137	CcSEcCtD
Estradiol—Dyspepsia—Dexamethasone—psoriasis	1.74e-05	0.000136	CcSEcCtD
Estradiol—Dyspepsia—Betamethasone—psoriasis	1.74e-05	0.000136	CcSEcCtD
Estradiol—Diarrhoea—Mycophenolate mofetil—psoriasis	1.73e-05	0.000136	CcSEcCtD
Estradiol—AR—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.73e-05	0.000449	CbGpPWpGaD
Estradiol—Urticaria—Triamcinolone—psoriasis	1.73e-05	0.000136	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—psoriasis	1.72e-05	0.000135	CcSEcCtD
Estradiol—Body temperature increased—Triamcinolone—psoriasis	1.72e-05	0.000135	CcSEcCtD
Estradiol—Dizziness—Cyclosporine—psoriasis	1.72e-05	0.000135	CcSEcCtD
Estradiol—Oedema—Prednisone—psoriasis	1.72e-05	0.000135	CcSEcCtD
Estradiol—Anaphylactic shock—Prednisone—psoriasis	1.72e-05	0.000135	CcSEcCtD
Estradiol—Decreased appetite—Dexamethasone—psoriasis	1.71e-05	0.000135	CcSEcCtD
Estradiol—Decreased appetite—Betamethasone—psoriasis	1.71e-05	0.000135	CcSEcCtD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.71e-05	0.000444	CbGpPWpGaD
Estradiol—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	1.71e-05	0.000443	CbGpPWpGaD
Estradiol—Infection—Prednisone—psoriasis	1.71e-05	0.000134	CcSEcCtD
Estradiol—Gastrointestinal disorder—Dexamethasone—psoriasis	1.7e-05	0.000134	CcSEcCtD
Estradiol—Gastrointestinal disorder—Betamethasone—psoriasis	1.7e-05	0.000134	CcSEcCtD
Estradiol—Back pain—Methotrexate—psoriasis	1.7e-05	0.000134	CcSEcCtD
Estradiol—Hypersensitivity—Hydrocortisone—psoriasis	1.7e-05	0.000133	CcSEcCtD
Estradiol—Fatigue—Dexamethasone—psoriasis	1.7e-05	0.000133	CcSEcCtD
Estradiol—Fatigue—Betamethasone—psoriasis	1.7e-05	0.000133	CcSEcCtD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.7e-05	0.00044	CbGpPWpGaD
Estradiol—AR—Generic Transcription Pathway—VDR—psoriasis	1.69e-05	0.000439	CbGpPWpGaD
Estradiol—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	1.69e-05	0.000438	CbGpPWpGaD
Estradiol—Shock—Prednisone—psoriasis	1.69e-05	0.000133	CcSEcCtD
Estradiol—ALB—Vitamin B12 Metabolism—TNF—psoriasis	1.69e-05	0.000437	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—IFNG—psoriasis	1.69e-05	0.000437	CbGpPWpGaD
Estradiol—Pain—Dexamethasone—psoriasis	1.69e-05	0.000132	CcSEcCtD
Estradiol—Pain—Betamethasone—psoriasis	1.69e-05	0.000132	CcSEcCtD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.69e-05	0.000437	CbGpPWpGaD
Estradiol—Nervous system disorder—Prednisone—psoriasis	1.68e-05	0.000132	CcSEcCtD
Estradiol—Tachycardia—Prednisone—psoriasis	1.68e-05	0.000132	CcSEcCtD
Estradiol—Dizziness—Mycophenolate mofetil—psoriasis	1.68e-05	0.000132	CcSEcCtD
Estradiol—Skin disorder—Prednisone—psoriasis	1.67e-05	0.000131	CcSEcCtD
Estradiol—Hyperhidrosis—Prednisone—psoriasis	1.66e-05	0.00013	CcSEcCtD
Estradiol—Asthenia—Hydrocortisone—psoriasis	1.66e-05	0.00013	CcSEcCtD
Estradiol—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	1.65e-05	0.000428	CbGpPWpGaD
Estradiol—Vomiting—Cyclosporine—psoriasis	1.65e-05	0.00013	CcSEcCtD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.65e-05	0.000427	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CYP2S1—psoriasis	1.64e-05	0.000425	CbGpPWpGaD
Estradiol—Rash—Cyclosporine—psoriasis	1.64e-05	0.000129	CcSEcCtD
Estradiol—Dermatitis—Cyclosporine—psoriasis	1.64e-05	0.000128	CcSEcCtD
Estradiol—Pruritus—Hydrocortisone—psoriasis	1.63e-05	0.000128	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—psoriasis	1.63e-05	0.000128	CcSEcCtD
Estradiol—Headache—Cyclosporine—psoriasis	1.63e-05	0.000128	CcSEcCtD
Estradiol—Feeling abnormal—Dexamethasone—psoriasis	1.62e-05	0.000128	CcSEcCtD
Estradiol—Feeling abnormal—Betamethasone—psoriasis	1.62e-05	0.000128	CcSEcCtD
Estradiol—CYP3A7—Metabolism—CYP2S1—psoriasis	1.62e-05	0.000421	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.62e-05	0.00042	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CYP2S1—psoriasis	1.62e-05	0.00042	CbGpPWpGaD
Estradiol—Gastrointestinal pain—Dexamethasone—psoriasis	1.61e-05	0.000127	CcSEcCtD
Estradiol—Gastrointestinal pain—Betamethasone—psoriasis	1.61e-05	0.000127	CcSEcCtD
Estradiol—Vomiting—Mycophenolate mofetil—psoriasis	1.61e-05	0.000126	CcSEcCtD
Estradiol—ABCB1—Allograft Rejection—IFNG—psoriasis	1.61e-05	0.000417	CbGpPWpGaD
Estradiol—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.61e-05	0.000416	CbGpPWpGaD
Estradiol—Hypersensitivity—Triamcinolone—psoriasis	1.6e-05	0.000126	CcSEcCtD
Estradiol—Rash—Mycophenolate mofetil—psoriasis	1.6e-05	0.000125	CcSEcCtD
Estradiol—Dermatitis—Mycophenolate mofetil—psoriasis	1.6e-05	0.000125	CcSEcCtD
Estradiol—Headache—Mycophenolate mofetil—psoriasis	1.59e-05	0.000125	CcSEcCtD
Estradiol—Malaise—Methotrexate—psoriasis	1.59e-05	0.000124	CcSEcCtD
Estradiol—Vertigo—Methotrexate—psoriasis	1.58e-05	0.000124	CcSEcCtD
Estradiol—Diarrhoea—Hydrocortisone—psoriasis	1.58e-05	0.000124	CcSEcCtD
Estradiol—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	1.58e-05	0.000408	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—CAT—psoriasis	1.57e-05	0.000406	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	1.57e-05	0.000406	CbGpPWpGaD
Estradiol—Urticaria—Dexamethasone—psoriasis	1.57e-05	0.000123	CcSEcCtD
Estradiol—Urticaria—Betamethasone—psoriasis	1.57e-05	0.000123	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Prednisone—psoriasis	1.56e-05	0.000123	CcSEcCtD
Estradiol—Dizziness—Prednisolone—psoriasis	1.56e-05	0.000123	CcSEcCtD
Estradiol—Asthenia—Triamcinolone—psoriasis	1.56e-05	0.000122	CcSEcCtD
Estradiol—Body temperature increased—Betamethasone—psoriasis	1.56e-05	0.000122	CcSEcCtD
Estradiol—Abdominal pain—Betamethasone—psoriasis	1.56e-05	0.000122	CcSEcCtD
Estradiol—Abdominal pain—Dexamethasone—psoriasis	1.56e-05	0.000122	CcSEcCtD
Estradiol—Body temperature increased—Dexamethasone—psoriasis	1.56e-05	0.000122	CcSEcCtD
Estradiol—Insomnia—Prednisone—psoriasis	1.55e-05	0.000122	CcSEcCtD
Estradiol—ESR1—Signaling Pathways—HCAR2—psoriasis	1.55e-05	0.000401	CbGpPWpGaD
Estradiol—Nausea—Cyclosporine—psoriasis	1.54e-05	0.000121	CcSEcCtD
Estradiol—Paraesthesia—Prednisone—psoriasis	1.54e-05	0.000121	CcSEcCtD
Estradiol—Pruritus—Triamcinolone—psoriasis	1.54e-05	0.000121	CcSEcCtD
Estradiol—Cough—Methotrexate—psoriasis	1.53e-05	0.00012	CcSEcCtD
Estradiol—Dizziness—Hydrocortisone—psoriasis	1.53e-05	0.00012	CcSEcCtD
Estradiol—SLC22A1—Metabolism—CYP2S1—psoriasis	1.51e-05	0.000392	CbGpPWpGaD
Estradiol—Dyspepsia—Prednisone—psoriasis	1.51e-05	0.000119	CcSEcCtD
Estradiol—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.51e-05	0.000391	CbGpPWpGaD
Estradiol—Nausea—Mycophenolate mofetil—psoriasis	1.5e-05	0.000118	CcSEcCtD
Estradiol—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.5e-05	0.000388	CbGpPWpGaD
Estradiol—Chest pain—Methotrexate—psoriasis	1.5e-05	0.000118	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—psoriasis	1.5e-05	0.000118	CcSEcCtD
Estradiol—Myalgia—Methotrexate—psoriasis	1.5e-05	0.000118	CcSEcCtD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.5e-05	0.000388	CbGpPWpGaD
Estradiol—Decreased appetite—Prednisone—psoriasis	1.49e-05	0.000117	CcSEcCtD
Estradiol—Rash—Prednisolone—psoriasis	1.49e-05	0.000117	CcSEcCtD
Estradiol—Dermatitis—Prednisolone—psoriasis	1.49e-05	0.000117	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	1.49e-05	0.000117	CcSEcCtD
Estradiol—AR—SIDS Susceptibility Pathways—TNF—psoriasis	1.48e-05	0.000384	CbGpPWpGaD
Estradiol—Fatigue—Prednisone—psoriasis	1.48e-05	0.000116	CcSEcCtD
Estradiol—Headache—Prednisolone—psoriasis	1.48e-05	0.000116	CcSEcCtD
Estradiol—Discomfort—Methotrexate—psoriasis	1.48e-05	0.000116	CcSEcCtD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.47e-05	0.000381	CbGpPWpGaD
Estradiol—Constipation—Prednisone—psoriasis	1.47e-05	0.000115	CcSEcCtD
Estradiol—Vomiting—Hydrocortisone—psoriasis	1.47e-05	0.000115	CcSEcCtD
Estradiol—Rash—Hydrocortisone—psoriasis	1.46e-05	0.000114	CcSEcCtD
Estradiol—Dermatitis—Hydrocortisone—psoriasis	1.45e-05	0.000114	CcSEcCtD
Estradiol—Confusional state—Methotrexate—psoriasis	1.45e-05	0.000114	CcSEcCtD
Estradiol—Headache—Hydrocortisone—psoriasis	1.45e-05	0.000114	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—TYK2—psoriasis	1.44e-05	0.000373	CbGpPWpGaD
Estradiol—Dizziness—Triamcinolone—psoriasis	1.44e-05	0.000113	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—psoriasis	1.44e-05	0.000113	CcSEcCtD
Estradiol—Infection—Methotrexate—psoriasis	1.43e-05	0.000112	CcSEcCtD
Estradiol—Feeling abnormal—Prednisone—psoriasis	1.42e-05	0.000111	CcSEcCtD
Estradiol—Asthenia—Dexamethasone—psoriasis	1.41e-05	0.000111	CcSEcCtD
Estradiol—Asthenia—Betamethasone—psoriasis	1.41e-05	0.000111	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—psoriasis	1.41e-05	0.00011	CcSEcCtD
Estradiol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.4e-05	0.000364	CbGpPWpGaD
Estradiol—Gastrointestinal pain—Prednisone—psoriasis	1.4e-05	0.00011	CcSEcCtD
Estradiol—Nausea—Prednisolone—psoriasis	1.4e-05	0.00011	CcSEcCtD
Estradiol—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	1.4e-05	0.000363	CbGpPWpGaD
Estradiol—Pruritus—Dexamethasone—psoriasis	1.4e-05	0.00011	CcSEcCtD
Estradiol—Pruritus—Betamethasone—psoriasis	1.4e-05	0.00011	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—psoriasis	1.39e-05	0.000109	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—psoriasis	1.39e-05	0.000109	CcSEcCtD
Estradiol—Vomiting—Triamcinolone—psoriasis	1.38e-05	0.000108	CcSEcCtD
Estradiol—CYP3A5—Metabolism—NDUFA5—psoriasis	1.38e-05	0.000358	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.38e-05	0.000358	CbGpPWpGaD
Estradiol—ALB—Platelet degranulation—VEGFA—psoriasis	1.37e-05	0.000356	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—TNF—psoriasis	1.37e-05	0.000356	CbGpPWpGaD
Estradiol—Nausea—Hydrocortisone—psoriasis	1.37e-05	0.000108	CcSEcCtD
Estradiol—Rash—Triamcinolone—psoriasis	1.37e-05	0.000108	CcSEcCtD
Estradiol—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.37e-05	0.000355	CbGpPWpGaD
Estradiol—Dermatitis—Triamcinolone—psoriasis	1.37e-05	0.000107	CcSEcCtD
Estradiol—AR—Gene Expression—CARM1—psoriasis	1.37e-05	0.000354	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—PPARG—psoriasis	1.36e-05	0.000353	CbGpPWpGaD
Estradiol—Urticaria—Prednisone—psoriasis	1.36e-05	0.000107	CcSEcCtD
Estradiol—ALB—Vitamin B12 Metabolism—IL6—psoriasis	1.36e-05	0.000353	CbGpPWpGaD
Estradiol—Headache—Triamcinolone—psoriasis	1.36e-05	0.000107	CcSEcCtD
Estradiol—Abdominal pain—Prednisone—psoriasis	1.36e-05	0.000107	CcSEcCtD
Estradiol—Body temperature increased—Prednisone—psoriasis	1.36e-05	0.000107	CcSEcCtD
Estradiol—Diarrhoea—Dexamethasone—psoriasis	1.35e-05	0.000106	CcSEcCtD
Estradiol—Diarrhoea—Betamethasone—psoriasis	1.35e-05	0.000106	CcSEcCtD
Estradiol—AR—Integrated Breast Cancer Pathway—TP53—psoriasis	1.34e-05	0.000348	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TAGAP—psoriasis	1.34e-05	0.000348	CbGpPWpGaD
Estradiol—ALB—Hemostasis—ITGAL—psoriasis	1.32e-05	0.000342	CbGpPWpGaD
Estradiol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	1.31e-05	0.000339	CbGpPWpGaD
Estradiol—Musculoskeletal discomfort—Methotrexate—psoriasis	1.31e-05	0.000103	CcSEcCtD
Estradiol—CYP1A1—Metabolism—NDUFA5—psoriasis	1.3e-05	0.000338	CbGpPWpGaD
Estradiol—ESR1—Generic Transcription Pathway—VDR—psoriasis	1.3e-05	0.000338	CbGpPWpGaD
Estradiol—Dizziness—Dexamethasone—psoriasis	1.3e-05	0.000102	CcSEcCtD
Estradiol—Dizziness—Betamethasone—psoriasis	1.3e-05	0.000102	CcSEcCtD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.3e-05	0.000336	CbGpPWpGaD
Estradiol—Insomnia—Methotrexate—psoriasis	1.3e-05	0.000102	CcSEcCtD
Estradiol—Nausea—Triamcinolone—psoriasis	1.29e-05	0.000101	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—psoriasis	1.29e-05	0.000101	CcSEcCtD
Estradiol—SLCO1B3—Metabolism—CARM1—psoriasis	1.29e-05	0.000333	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.28e-05	0.000332	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.28e-05	0.000332	CbGpPWpGaD
Estradiol—Dyspnoea—Methotrexate—psoriasis	1.28e-05	0.0001	CcSEcCtD
Estradiol—Somnolence—Methotrexate—psoriasis	1.28e-05	0.0001	CcSEcCtD
Estradiol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	1.27e-05	0.000329	CbGpPWpGaD
Estradiol—Hypersensitivity—Prednisone—psoriasis	1.27e-05	9.93e-05	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—psoriasis	1.26e-05	9.92e-05	CcSEcCtD
Estradiol—SLC22A3—Metabolism—CARM1—psoriasis	1.26e-05	0.000327	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.26e-05	0.000327	CbGpPWpGaD
Estradiol—Vomiting—Betamethasone—psoriasis	1.25e-05	9.84e-05	CcSEcCtD
Estradiol—Vomiting—Dexamethasone—psoriasis	1.25e-05	9.84e-05	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—CXCL8—psoriasis	1.25e-05	0.000325	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.25e-05	0.000324	CbGpPWpGaD
Estradiol—Decreased appetite—Methotrexate—psoriasis	1.25e-05	9.79e-05	CcSEcCtD
Estradiol—ESR2—Gene Expression—VDR—psoriasis	1.25e-05	0.000323	CbGpPWpGaD
Estradiol—Rash—Dexamethasone—psoriasis	1.24e-05	9.76e-05	CcSEcCtD
Estradiol—Rash—Betamethasone—psoriasis	1.24e-05	9.76e-05	CcSEcCtD
Estradiol—Dermatitis—Betamethasone—psoriasis	1.24e-05	9.75e-05	CcSEcCtD
Estradiol—Dermatitis—Dexamethasone—psoriasis	1.24e-05	9.75e-05	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—psoriasis	1.24e-05	9.73e-05	CcSEcCtD
Estradiol—Fatigue—Methotrexate—psoriasis	1.24e-05	9.71e-05	CcSEcCtD
Estradiol—Headache—Dexamethasone—psoriasis	1.24e-05	9.7e-05	CcSEcCtD
Estradiol—Headache—Betamethasone—psoriasis	1.24e-05	9.7e-05	CcSEcCtD
Estradiol—NR1I2—Gene Expression—PPARG—psoriasis	1.23e-05	0.00032	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.23e-05	0.000319	CbGpPWpGaD
Estradiol—Asthenia—Prednisone—psoriasis	1.23e-05	9.67e-05	CcSEcCtD
Estradiol—Pain—Methotrexate—psoriasis	1.23e-05	9.63e-05	CcSEcCtD
Estradiol—ESRRA—Metabolism—APOE—psoriasis	1.22e-05	0.000316	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.22e-05	0.000315	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.22e-05	0.000315	CbGpPWpGaD
Estradiol—Pruritus—Prednisone—psoriasis	1.21e-05	9.54e-05	CcSEcCtD
Estradiol—ALB—Folate Metabolism—TP53—psoriasis	1.21e-05	0.000314	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.2e-05	0.000311	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—IL6—psoriasis	1.2e-05	0.00031	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NDUFA5—psoriasis	1.2e-05	0.00031	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—IL6—psoriasis	1.19e-05	0.000309	CbGpPWpGaD
Estradiol—ALB—Metabolism—NDUFA5—psoriasis	1.19e-05	0.000308	CbGpPWpGaD
Estradiol—Feeling abnormal—Methotrexate—psoriasis	1.18e-05	9.28e-05	CcSEcCtD
Estradiol—AR—Generic Transcription Pathway—PPARG—psoriasis	1.18e-05	0.000306	CbGpPWpGaD
Estradiol—Diarrhoea—Prednisone—psoriasis	1.17e-05	9.22e-05	CcSEcCtD
Estradiol—CYP3A5—Metabolism—CYP2S1—psoriasis	1.17e-05	0.000304	CbGpPWpGaD
Estradiol—Gastrointestinal pain—Methotrexate—psoriasis	1.17e-05	9.21e-05	CcSEcCtD
Estradiol—Nausea—Dexamethasone—psoriasis	1.17e-05	9.19e-05	CcSEcCtD
Estradiol—Nausea—Betamethasone—psoriasis	1.17e-05	9.19e-05	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—JUN—psoriasis	1.17e-05	0.000302	CbGpPWpGaD
Estradiol—Urticaria—Methotrexate—psoriasis	1.14e-05	8.95e-05	CcSEcCtD
Estradiol—Dizziness—Prednisone—psoriasis	1.14e-05	8.91e-05	CcSEcCtD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.13e-05	0.000294	CbGpPWpGaD
Estradiol—Abdominal pain—Methotrexate—psoriasis	1.13e-05	8.91e-05	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—psoriasis	1.13e-05	8.91e-05	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—NFKB1—psoriasis	1.12e-05	0.000291	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.12e-05	0.000289	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.11e-05	0.000288	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CYP2S1—psoriasis	1.11e-05	0.000287	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.11e-05	0.000287	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—IL6—psoriasis	1.11e-05	0.000287	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.11e-05	0.000286	CbGpPWpGaD
Estradiol—Vomiting—Prednisone—psoriasis	1.09e-05	8.57e-05	CcSEcCtD
Estradiol—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.09e-05	0.000283	CbGpPWpGaD
Estradiol—AOX1—Metabolism—CAT—psoriasis	1.09e-05	0.000281	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.08e-05	0.000281	CbGpPWpGaD
Estradiol—Rash—Prednisone—psoriasis	1.08e-05	8.5e-05	CcSEcCtD
Estradiol—Dermatitis—Prednisone—psoriasis	1.08e-05	8.49e-05	CcSEcCtD
Estradiol—AOX1—Disease—HLA-A—psoriasis	1.08e-05	0.00028	CbGpPWpGaD
Estradiol—Headache—Prednisone—psoriasis	1.08e-05	8.45e-05	CcSEcCtD
Estradiol—CYP2C19—Metabolism—NDUFA5—psoriasis	1.07e-05	0.000277	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—PPARG—psoriasis	1.06e-05	0.000275	CbGpPWpGaD
Estradiol—Hypersensitivity—Methotrexate—psoriasis	1.06e-05	8.3e-05	CcSEcCtD
Estradiol—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.05e-05	0.000273	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—CARM1—psoriasis	1.05e-05	0.000272	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—TNF—psoriasis	1.04e-05	0.00027	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NDUFA5—psoriasis	1.04e-05	0.00027	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.04e-05	0.000268	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.03e-05	0.000268	CbGpPWpGaD
Estradiol—Asthenia—Methotrexate—psoriasis	1.03e-05	8.08e-05	CcSEcCtD
Estradiol—Nausea—Prednisone—psoriasis	1.02e-05	8.01e-05	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—VEGFA—psoriasis	1.02e-05	0.000264	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP2S1—psoriasis	1.02e-05	0.000263	CbGpPWpGaD
Estradiol—Pruritus—Methotrexate—psoriasis	1.02e-05	7.97e-05	CcSEcCtD
Estradiol—ALB—Metabolism—CYP2S1—psoriasis	1.01e-05	0.000262	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CARM1—psoriasis	1.01e-05	0.000262	CbGpPWpGaD
Estradiol—AOX1—Disease—APOE—psoriasis	1.01e-05	0.000261	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—STAT3—psoriasis	1.01e-05	0.000261	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.96e-06	0.000258	CbGpPWpGaD
Estradiol—Diarrhoea—Methotrexate—psoriasis	9.82e-06	7.71e-05	CcSEcCtD
Estradiol—CYP2C9—Metabolism—NDUFA5—psoriasis	9.74e-06	0.000252	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.72e-06	0.000252	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	9.68e-06	0.000251	CbGpPWpGaD
Estradiol—Dizziness—Methotrexate—psoriasis	9.49e-06	7.45e-05	CcSEcCtD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.45e-06	0.000245	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.44e-06	0.000245	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CARM1—psoriasis	9.43e-06	0.000244	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—IL6—psoriasis	9.42e-06	0.000244	CbGpPWpGaD
Estradiol—AOX1—Disease—NOS2—psoriasis	9.39e-06	0.000243	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.28e-06	0.00024	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	9.24e-06	0.000239	CbGpPWpGaD
Estradiol—Vomiting—Methotrexate—psoriasis	9.12e-06	7.16e-05	CcSEcCtD
Estradiol—ESR1—Generic Transcription Pathway—PPARG—psoriasis	9.09e-06	0.000236	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP2S1—psoriasis	9.08e-06	0.000235	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.08e-06	0.000235	CbGpPWpGaD
Estradiol—Rash—Methotrexate—psoriasis	9.05e-06	7.1e-05	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—psoriasis	9.04e-06	7.1e-05	CcSEcCtD
Estradiol—Headache—Methotrexate—psoriasis	8.99e-06	7.06e-05	CcSEcCtD
Estradiol—ABCB1—Metabolism—CYP2S1—psoriasis	8.86e-06	0.00023	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—IL6—psoriasis	8.81e-06	0.000228	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CARM1—psoriasis	8.8e-06	0.000228	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—PPARG—psoriasis	8.68e-06	0.000225	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CARM1—psoriasis	8.64e-06	0.000224	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.57e-06	0.000222	CbGpPWpGaD
Estradiol—Nausea—Methotrexate—psoriasis	8.52e-06	6.69e-05	CcSEcCtD
Estradiol—AOX1—Metabolism—APOE—psoriasis	8.44e-06	0.000219	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NDUFA5—psoriasis	8.32e-06	0.000215	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP2S1—psoriasis	8.28e-06	0.000214	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.22e-06	0.000213	CbGpPWpGaD
Estradiol—AR—Gene Expression—VDR—psoriasis	8.15e-06	0.000211	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.08e-06	0.000209	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL20—psoriasis	8.04e-06	0.000208	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CARM1—psoriasis	8e-06	0.000207	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CARM1—psoriasis	7.93e-06	0.000205	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CARM1—psoriasis	7.92e-06	0.000205	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—CAT—psoriasis	7.91e-06	0.000205	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—CAT—psoriasis	7.77e-06	0.000201	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.76e-06	0.000201	CbGpPWpGaD
Estradiol—AOX1—Disease—TYK2—psoriasis	7.69e-06	0.000199	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—TP53—psoriasis	7.69e-06	0.000199	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CARM1—psoriasis	7.38e-06	0.000191	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PPARG—psoriasis	7.35e-06	0.00019	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP2S1—psoriasis	7.07e-06	0.000183	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—IL6—psoriasis	7.04e-06	0.000182	CbGpPWpGaD
Estradiol—AOX1—Disease—CD4—psoriasis	6.96e-06	0.00018	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.87e-06	0.000178	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	6.61e-06	0.000171	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NDUFA5—psoriasis	6.42e-06	0.000166	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—VDR—psoriasis	6.28e-06	0.000163	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CAT—psoriasis	6.22e-06	0.000161	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—APOE—psoriasis	6.15e-06	0.000159	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	6.1e-06	0.000158	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—APOE—psoriasis	6.04e-06	0.000156	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	6e-06	0.000155	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.81e-06	0.000151	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CAT—psoriasis	5.8e-06	0.00015	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CARM1—psoriasis	5.73e-06	0.000149	CbGpPWpGaD
Estradiol—AR—Gene Expression—PPARG—psoriasis	5.68e-06	0.000147	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP2S1—psoriasis	5.46e-06	0.000141	CbGpPWpGaD
Estradiol—ALB—Hemostasis—NOS2—psoriasis	5.42e-06	0.000141	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CARM1—psoriasis	5.42e-06	0.00014	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CAT—psoriasis	5.41e-06	0.00014	CbGpPWpGaD
Estradiol—AOX1—Disease—STAT3—psoriasis	5.39e-06	0.00014	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PPARG—psoriasis	5.36e-06	0.000139	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.33e-06	0.000138	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CAT—psoriasis	5.32e-06	0.000138	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.3e-06	0.000137	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PPARG—psoriasis	5.26e-06	0.000136	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	5.14e-06	0.000133	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.06e-06	0.000131	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CARM1—psoriasis	4.97e-06	0.000129	CbGpPWpGaD
Estradiol—ALB—Metabolism—CARM1—psoriasis	4.94e-06	0.000128	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CAT—psoriasis	4.92e-06	0.000128	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CAT—psoriasis	4.88e-06	0.000126	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CAT—psoriasis	4.87e-06	0.000126	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—APOE—psoriasis	4.83e-06	0.000125	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.76e-06	0.000123	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.64e-06	0.00012	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.62e-06	0.00012	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CAT—psoriasis	4.54e-06	0.000118	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.54e-06	0.000117	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—APOE—psoriasis	4.51e-06	0.000117	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CARM1—psoriasis	4.43e-06	0.000115	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SOCS1—psoriasis	4.43e-06	0.000115	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—PPARG—psoriasis	4.38e-06	0.000113	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.34e-06	0.000112	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CARM1—psoriasis	4.33e-06	0.000112	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PPARG—psoriasis	4.21e-06	0.000109	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—APOE—psoriasis	4.2e-06	0.000109	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.14e-06	0.000107	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—APOE—psoriasis	4.13e-06	0.000107	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CARM1—psoriasis	4.04e-06	0.000105	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PPARG—psoriasis	3.93e-06	0.000102	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—APOE—psoriasis	3.83e-06	9.91e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—APOE—psoriasis	3.79e-06	9.82e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—APOE—psoriasis	3.79e-06	9.81e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.78e-06	9.79e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—IL6—psoriasis	3.76e-06	9.75e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.71e-06	9.6e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PPARG—psoriasis	3.66e-06	9.49e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PPARG—psoriasis	3.6e-06	9.32e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—APOE—psoriasis	3.53e-06	9.14e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CAT—psoriasis	3.53e-06	9.14e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CARM1—psoriasis	3.45e-06	8.95e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CAT—psoriasis	3.33e-06	8.63e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PPARG—psoriasis	3.33e-06	8.63e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PPARG—psoriasis	3.3e-06	8.55e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PPARG—psoriasis	3.3e-06	8.54e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—APOE—psoriasis	3.27e-06	8.47e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—LEP—psoriasis	3.27e-06	8.47e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.23e-06	8.36e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—VEGFA—psoriasis	3.14e-06	8.14e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PPARG—psoriasis	3.07e-06	7.96e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CAT—psoriasis	3.06e-06	7.91e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NFKBIA—psoriasis	3.05e-06	7.89e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CAT—psoriasis	3.04e-06	7.87e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—APOE—psoriasis	2.74e-06	7.1e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CAT—psoriasis	2.73e-06	7.06e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CARM1—psoriasis	2.67e-06	6.91e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CAT—psoriasis	2.66e-06	6.89e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—APOE—psoriasis	2.59e-06	6.71e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TYK2—psoriasis	2.49e-06	6.46e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CAT—psoriasis	2.49e-06	6.44e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PPARG—psoriasis	2.39e-06	6.18e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—psoriasis	2.37e-06	6.15e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—APOE—psoriasis	2.37e-06	6.15e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—APOE—psoriasis	2.36e-06	6.11e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PPARG—psoriasis	2.26e-06	5.84e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL8—psoriasis	2.17e-06	5.63e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CAT—psoriasis	2.12e-06	5.5e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—APOE—psoriasis	2.12e-06	5.49e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—APOE—psoriasis	2.07e-06	5.36e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PPARG—psoriasis	2.07e-06	5.36e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PPARG—psoriasis	2.06e-06	5.33e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—JUN—psoriasis	2.02e-06	5.23e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NFKB1—psoriasis	1.94e-06	5.03e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—APOE—psoriasis	1.93e-06	5e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PPARG—psoriasis	1.85e-06	4.78e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PPARG—psoriasis	1.8e-06	4.67e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—VEGFA—psoriasis	1.76e-06	4.57e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—STAT3—psoriasis	1.75e-06	4.52e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PPARG—psoriasis	1.68e-06	4.36e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—APOE—psoriasis	1.65e-06	4.28e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CAT—psoriasis	1.64e-06	4.25e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PPARG—psoriasis	1.44e-06	3.72e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—psoriasis	1.33e-06	3.45e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—APOE—psoriasis	1.27e-06	3.3e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL6—psoriasis	1.22e-06	3.16e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PPARG—psoriasis	1.11e-06	2.87e-05	CbGpPWpGaD
